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Background: Despite readily detectable levels of the HIV-1 (co)-receptors CD4, CCR5 and DC-SIGN on placental
macrophages (Hofbauer Cells [HCs]), the rate of HIV-1 infection in utero in the absence of interventions is only 7%
of exposed infants. Here, we examine the replication kinetics of human HCs to the primary isolate HIV-1BaL. We also
determined the infectivity of HIV-1-exposed HCs by co-culturing with isolated cord and peripheral blood
mononuclear cells [CBMCs, PBMCs]. To understand the limiting nature of HCs to HIV-1 replication, we examined the
effect of endogenously secreted cytokines on replication kinetics.
Results: HCs have reduced ability to replicate HIV-1 in vitro (p < 0.01) and to transmit virus to CBMCs and PBMCs (p
< 0.001 for both) compared to standard infections of MDMs. HCs were shown to release HIV-1 particles at levels
comparable to MDMs, however exhibit significant decreases in viral transcription (gag and env), which may account
for lower levels of HIV-1 replication. Un-stimulated HCs constitutively express significantly higher levels of regulatory
cytokines, IL-10 and TGF-β, compared to MDMs (p < 0.01), which may contribute to immunoregulatory
predominance at the placenta and possibly account for down-regulation of HIV-1 replication and infectivity by HCs.
We further demonstrate that these regulatory cytokines inhibit HIV-1 replication within HCs in vitro.
Conclusion: HCs have reduced ability to replicate and disseminate R5-tropic HIV-1BaL in vitro and potentially offset
mother to child transmission (MTCT) of HIV-1 by the induction of immunoregulatory cytokines. Despite the
potential for migration and infectivity, HCs are not present in the neighboring fetal circulation. These results
implicate HCs as important mediators of protection at the feto-maternal interface during ongoing HIV-1 exposure.
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In 2008, UNAIDS estimated that 430,000 new HIV-1
infections occurred in children under 15 years of age;
most occurred from mother to child transmission
(MTCT) during labor and delivery or through breast-
feeding [1]. The risk of in utero transmission, however, is
less than 7%; so that even in the absence of virologic
suppression with maternal antiretroviral therapy, over
90% of HIV-1-exposed newborns are “naturally”* Correspondence: rchakr5@emory.edu
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distribution, and reproduction in any mediumprotected from infection in utero. These observations
suggest the placenta has evolved mechanisms that re-
strict establishment of viral infection at the feto-
maternal interface. Elucidating these mechanisms may
help determine biologic correlates of protection against
HIV-1 transmission in humans.
Cytokines influence placental development, fetal
growth and immunity, and HIV-1 replication in infected
cells [2]. Thus, while strong TH1-prototype cytokine
responses are associated with recurrent abortions [3]
and enhanced HIV-1 replication in vitro [4], regulatory
cytokine responses have been shown to inhibit HIV-1
replication [5]. Placentas from non-transmitting mothersMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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while placentas from transmitting mothers exhibit a
pro-inflammatory pattern of cytokine release [5]. It is
unknown whether this intrinsic immunoregulatory adap-
tion within the placenta limits HIV-1 replication, thereby
offsetting vertical transmission.
The feto-maternal interface is characterized by intim-
ate contact between uterine decidual cells and invading
chorionic villi. An individual villus is lined by tropho-
blasts, which enclose connective tissue stroma containing
fetal blood vessels and numerous placental macrophages
or Hofbauer cells (HCs). The chorionic villi are directly
bathed in maternal blood. An HIV-1 virion can poten-
tially encounter HCs after breaching the trophoblast cell
layer. Intriguingly, HCs express the HIV-1 (co)-receptors
CD4, CCR5 and CXCR4, and also DC-SIGN on their cell
surface [6]. DC-SIGN is a calcium-dependent lectin
which binds HIV-1 gp120 with a greater affinity than
CD4 [7]. The presence of virus has been detected histo-
logically in HCs [8], which appear to be ideal targets to
facilitate HIV-1 transmission. Despite this phenotype the
risk of in utero transmission remains very low.
Several studies have demonstrated potential modes of
HIV-1 transplacental passage [9,10]. Recently, maternal
cells were identified in fetal lymph nodes and noted to
induce the development of T regulatory cells that sup-
press fetal anti-maternal immunity [11]. It would seem
plausible that the fetus of an HIV-1-infected mother
may be exposed to free and cell-associated virus during
gestation. The relatively low risk of in utero transmission
points to innate and adaptive mechanisms that have
evolved in humans to restrict lentiviral infection within
the placenta.
We investigated the hypothesis that placental macro-
phages (HCs) limit HIV-1 replication compared to
MDMs through the production and response to regula-
tory cytokines. Our group and others have reported that
HCs exhibit reduced ability to replicate HIV-1 in vitro
[12,13]. This restriction of HIV-1 replication may occur
at the level of viral transcription. To further examine the
limiting nature of HCs to viral replication, we examined
the phenotype and cytokine profile of these placental
macrophages. We noted that cytokines expressed by
HCs have inhibitory effects on HIV-1 replication in vitro
and that despite the potential for migration and infectiv-
ity, HCs are not present in the neighboring fetal circula-
tion. These results implicate HCs as important
mediators of protection at the feto-maternal interface
during HIV-1 exposure.
Results
HCs are potential targets for HIV-1 infection
We analyzed the cell surface expression of molecules
involved in HIV-1 entry and activation on HCs isolatedfrom term placentas. CD14+ HCs express the HIV-1 co-
receptors CD4, DC-SIGN and CCR5, and to a lesser
extent CXCR4 (Figure 1A). Compared to monocyte-
derived macrophages (MDMs), HCs express similar
levels of CCR5 and CXCR4. The percentage fluorescence
expression of CD4 on HCs was less than in MDMs, and
detectable concentrations of DC-SIGN were only noted
on the cell surface of HCs. T-cell activation requires co-
stimulatory signals through binding of the CD28 recep-
tor with cognate ligands, CD80/CD86, located on the
surface of antigen presenting cells (APCs). When co-
stimulation is coupled with a signal through the T-cell
receptor (TCR), T-cell proliferation and cytokine secre-
tion are induced. HCs and MDMs expressed comparable
levels of MHC class II cell surface receptor, HLA-DR;
however, lower levels of CD80 were expressed on HCs,
while CD86 was similar to that expressed by MDMs
(Figure 1B). These results may suggest that HCs possess
the ability to engage the TCR, but without sufficient
CD80 stimulation are unable to induce a robust T-cell
response.
HCs have reduced ability to replicate HIV-1 compared to
MDMs
Since HCs are susceptible to HIV-1 infection, studies
were conducted to determine the potential permissive-
ness of decidual HCs to experimental in vitro infection
using cell-free HIV-1. We compared HIV-1 replication
in HCs to MDMs using R5-tropic HIV-1BaL at a TCID50
of 0.2 per cell. HCs were productively infected, as
observed by a detectable increase in the levels of p24 in
the supernatant fluid over time, ranging from 0–10 ng/ml
(Figure 2A). Mean p24 antigen production in HCs was
significantly less than that detected in MDMs cultured in
parallel at the same TCID50 (p < 0.01). The exact magni-
tude of restriction varied slightly from donor to donor,
but the reduced ability of HCs to replicate HIV-1 in vitro
was consistent for each donor [(N =16) (see Additional
files 1 and 2). To verify HCs are productively infected
with HIV-1, we utilized electron microscopy (EM) studies
to demonstrate viral assembly within intracellular
compartments and at the plasma membrane surface
(see Additional file 3). To examine HIV-1 assembly
and release in HCs, we compared particle release effi-
ciency between the HCs and MDMs. Levels of HIV-1 re-
lease are expressed as a percentage of p24 antigen in
supernatants as a fraction of p24 antigen in supernatant
plus cell lysate. No significant differences were found
in particle release between the two cell types
(Figure 2B). These results indicate restriction does not
occur at the point of particle assembly/release. To fur-
ther account for the reduced ability of HCs to repli-
cate HIV-1, we monitored viral gene transcription 6
days post infection using real-time PCR. We found that
Figure 1 HCs are potential targets for HIV-1 infection but express low levels of the co-stimulatory signal CD80. The cell surface
expression of molecules involved in (A) HIV-1 entry and (B) activation were analyzed on HCs and MDMs. Fluorescence intensity was measured in
cells incubated with antibodies against the pattern recognition receptor (CD14), the co-stimulatory markers (CD80-PE and CD86-APC), MHC II
marker (HLA-DR-PE) and HIV-1 receptors (CD4-APC, CCR5-PerCp-Cy5.5, CXCR4-PE-Cy7, and DC-SIGN-PE). (A) Phenotypic markers are represented as
a percentage of expression in purified populations of HCs and MDMs. Results are presented as a mean percentage (±SE) of the total population,
which are positive for the marker. Data shown are representative of three independent experiments from different donors (* p < 0.05, **p < 0.01).
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mRNA (average Ct values) and a 119-fold decrease in
env mRNA compared to HIV-1-infected MDMs
(Figure 2C). These results demonstrate that HCs have
decrease levels of viral transcription, which may account
for lower levels of HIV-1 replication. To rule out any
possible effect on cell viability that might interfere with
the evaluation of HIV-1 replication, a colorometric
MTT assay was performed to measure the cell viability.
Based on this assay, no significant difference in cell via-
bility was observed on comparing uninfected and HIV-1-
infected MDMs and HCs; therefore, the effect is not a
consequence of reduced cell viability (Figure 2D). These
results demonstrate that placental HCs are permissive
to HIV-1BaL but replicate virus to a significantly lesser
extent than MDMs. The findings are consistent with
observations on decidual CD14+ cells and placental tis-
sue obtained from the first trimester of pregnancy which
were also permissive to R5 HIV-1 infection but to a lesser
degree than peripheral blood macrophages [14].
HIV-1-infected HCs have limited capacity to transmit virus
to cord blood mononuclear cells (CBMCs)
HIV-1BaL-infected HCs (or MDMs) were co-cultured
with PHA-activated CBMCs. After 6 hours of culture,
non-adherent CBMCs were collected and cultured sep-
arately from HCs. CBMCs co-cultured with HIV-1-
infected HCs had significantly lower concentrations ofp24 than CBMCs co-cultured with HIV-1-infected MDM’s
(Figure 3A). A similar trend was also noted with PBMCs
(Figure 3B). HIV-1-infected HCs can productively trans-
mit virus to neighboring CBMCs, however their relative
capacity to disseminate virus is significantly less than
MDMs.
Placental HCs may offset MTCT by inducing regulatory
cytokines
Since cytokines have been noted to influence the suscep-
tibility of hematopoietic cells to HIV-1 infection, the
supernatant of HCs, and for comparison MDMs, were
assayed for a battery of cytokines. Purified HCs and
MDMs were cultured with media alone or media con-
taining R5-tropic HIV-1BaL for 48 h and the supernatant
analyzed for the concentrations of IL-4, IL-6, IL-10,
TGF-β1, TNF-α and IFN-γ. Similar to previously
described regulatory macrophages [15], supernatant from
HCs constitutively expressed significantly higher concen-
trations of the immunosuppressive cytokines IL-10 and
TGF-β1 compared to un-stimulated MDMs (Figure 4).
IL-10 expression increased significantly in HIV-1-infected
HCs compared to uninfected cells, while TGF-β expres-
sion remained unchanged. The TH1 cytokine TNF-α
was significantly up-regulated in HCs at baseline,
while HIV-1 infection caused a reduction in secreted
TNF-α comparable to infected-MDMs (Figure 4). Thus
HCs intrinsically exhibit immunosuppressive cytokine
Figure 2 HIV-1 replication in HCs and MDMs. Since HCs appear to be primary targets for HIV-1 infection, we compared HIV-1 replication in
HCs to MDMs. HCs (closed square) and MDMs (open square) infected by HIV-1BaL in vitro showed differences in HIV-replication over time. HIV-1
replication was measured in the cell supernatants by HIV-1 p24 viral antigen ELISA (A). HIV-1 release over time from HCs and MDMs was
quantified as the percentage of p24 antigen in supernatants as a fraction of p24 antigen in supernatant plus cell lysate (B). Six days post
infection, mRNA levels were measured by real-time PCR to determine fold-changes in env and gag transcription (C). Cell cytotoxicity was assessed
by MTT assay (D). The ratio of optical density from infected cells to optical density from control cells reflected the percentage of surviving cells.
Data shown are expressed as the mean ± SE of triplicate samples and are representative of 3 independent experiments from 10 different donors
(**p < 0.01).
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at the feto-maternal interface [11]; this adaptation is
observed following HIV-1 infection of HCs in vitro.
Exogenous regulatory cytokines, normally expressed by
the placenta, inhibit HIV-1 replication in HCs in vitro
HCs were pretreated with or without IL-10, TGF-β,
IL-4, IL-6, IFN-γ, and TNF-α prior to infection with
HIV-1BaL. Regulatory cytokines, IL-10 and TGF-β, sig-
nificantly lowered HIV-1 replication by HCs over time
(Figure 5). Exogenous administration of IL-4 did not
influence, while IL-6 induced a slight decrease in HIV-1
replication. Interestingly, the prototypic TH1 cytokine,
IFN-γ, stimulated a drastic reduction in HIV-1 replica-
tion in HCs. However, mean p24 antigen production
was significantly higher in HIV-1-infected HCs treated
with TNF-α. Numerous studies have demonstrated the
dichotomous effects of cytokines on HIV-1 replication
by MDMs. Generally, inflammatory cytokines signifi-
cantly up-regulate HIV-1 replication in human macro-
phages [16], while immunoregulatory cytokines have the
converse effect by suppressing viral replication in these
cells [17]. These data suggest that differential cytokinesignaling at the feto-maternal interface may provide an
environment that limits HIV-1 replication within HCs
upon infection.
HCs migrate at similar rates to MDMs after stimulation by
CCR5 ligands in vitro but are not detected in the cord
blood
HCs and MDMs express CCR5, which typically facili-
tates their mobilization towards MIP-1α and MIP-1β
upon activation. In order to examine HC-CCR5-induced
migration, in vitro assays were used to quantify the
number of cells that migrated in response to control
media, and media conditioned with MIP-1α and
MIP-1β. Migration in HCs and MDMs towards MIP-1α
and MIP-1β was CCR5-mediated, and was abrogated by
the addition of specific CCR5 antibody. While HCs and
MDMs migrated at comparable rates in response to
MIP-1β, HCs migrated towards MIP-1α less vigorously
than MDMs in repeated experiments (Figure 6A).
Therefore, HCs do possess the ability to migrate in a
CCR5-dependent manner similar to macrophages. How-
ever, HCs were not detected in cord blood by flow cyto-
metry (Figure 6B). These findings suggest that HCs lack
Figure 3 HIV-1-infected HCs have the capacity to infect CBMCs and PBMCs. In order to determine the infectivity of HCs, HIV-1BaL infected
HCs and MDMs were co-cultivated separately with (A) CBMCs and (B) PBMCs. After 6 h, the CBMCs and PBMCs were cultured separately, and
HIV-1 replication was measured in the cell supernatants by HIV-1 p24 viral antigen ELISA. Closed squares represent HC-infected cells and open
squares indicate MDM-infected cells. Data shown are expressed as the mean ± SE of triplicate samples and are representative of 3 independent
experiments from different donors (**p < 0.01; ***p < 0.001).
Figure 4 Placental HCs may offset MTCT by inducing TH2 cytokine bias. HCs and MDMs were either infected with HIV-1BaL, or left
uninfected for 48 h. Supernatants were collected and measured for production of IL-10, TGF-β, IL-6, and TNF-α. Cytokines were measured using a
Quantikine ELISA assay. Data shown are expressed as the mean ± SE of triplicate samples and are representative of 3 independent experiments
from different donors (* p < 0.05, **p < 0.01).
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Figure 5 Exogenous TH2-type cytokines, IL-10 and TGF-β, have inhibitory effects on HIV-1 replication in HCs. HCs were left untreated or
pretreated for with IL-10, TGF-β, TNF-α, IFN-γ, IL-4 and IL-6 prior to infection with HIV-1BaL. HIV-1 replication was measured in the cell supernatants
by HIV-1 p24 viral antigen ELISA. Data shown are expressed as the mean ± SE of triplicate samples and are representative of 3 independent
experiments from different donors (* p < 0.05, **p < 0.01).
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pite their abundance within the chorionic villi, associ-
ation with neighboring umbilical vessels, and ability to
migrate in vitro after stimulation with CCR5 ligands.
Discussion
The placenta represents a unique immunologic site
populated with specialized APCs, specifically HCs. Fetal
tolerance involves the interplay of immunologic cells
within this interface [18-20]; however, their role in
HIV-1 transmission is poorly defined. Here, we report
that HCs have reduced ability to replicate and dissemin-
ate R5-tropic HIV-1BaL in vitro and potentially offset
MTCT of HIV-1 by the induction of immunoregulatory
cytokines. In order for induction of antigen-specific tol-
erance, there is on-going bi-directional trafficking of im-
mune cells in utero between mother and fetus [11]. This
continuous two-way transfer causes maternal immune
cells and free virus (during HIV-1 infection) to interact
directly with HCs. We demonstrate that HCs co-express
CD4, CCR5 and CXCR4, and that these cells are suscep-
tible in vitro to HIV-1BaL infection. Similar to DCs, but
unlike peripheral macrophages, HCs express very high
levels of DC-SIGN [21]. During pregnancy, there is
increased expression of DC-SIGN on HCs; thisexpression has been correlated with increased rates of
HIV-1 vertical transmission [22]. Intuitively, the pres-
ence of DC-SIGN and HIV-1 (co)-receptors on HCs,
could promote viral entry by free or cell-mediated trans-
mission of HIV-1 facilitating infection in the unborn
fetus. Despite this phenotype, MTCT events are rare in
utero which suggest that HCs may be key mediators of
protection during HIV-1 exposure. T-cell activation
involves specific binding of the T-cell receptor to the
antigen/MHC class II complex and requires a second
signal mediated by the simultaneous binding of co-
stimulatory molecules CD80 and CD86 on APCs. HCs
appear to have the ability to engage the T-cell receptor,
but without sufficient CD80 co-stimulation, may be un-
able to induce an immunologic response characterized
by T-cell activation. Our data are supported by observa-
tions that HCs inhibit T-cell responses in mixed
lymphocyte reactions compared to peripheral blood
monocytes [23], and induce T-cell anergy in the placenta
[24]. Reports also suggest that expression of CD80 and
CD86 on APCs is regulated by cytokines like IL-10 [25].
HCs support infection and replication in vitro with
HIV-1BaL but mean p24 antigen production is signifi-
cantly less than in peripheral blood MDMs. These data
reflect observations in decidual CD14+ cells and
Figure 6 MIP-1α and MIP-1β induce CCR5-mediated chemotaxis of HCs in vitro but are not detected in the cord blood. MIP-1α and
MIP-1β ligands for the CCR5 receptor play an important role in modulating immune responses. To examine CCR5-induced migration (A), HCs and
MDMs were pretreated with or without human CCR5 monoclonal antibody (5 μg/ml), placed in Transwell inserts, and stimulated with MIP-1α
(10 ng/ml) and MIP-1β (10 ng/ml). Results are expressed as chemotactic index (CI). CI is calculated by dividing the mean number of cells
migrating toward chemoattractants by that toward control medium. Data shown are means ± SE of three independent experiments from
different donors (* p < 0.05). To detect the presence of HCs in cord blood (B), cells were stained with PE-DC-SIGN, PE-Cy7-CD4, PerCP-CCR5,
PE-Cy7-CXCR4, PE-HLA-ABC, APC-HLA-DR, APC-CD11b, PE-CD11c, PE-83, APC-CD86, and FITC-CD14. Quadrants were set according to uninfected
control staining. Cells were gated on CD14+ cells. Flow cytometry pictures show a representative of 5 different donors.
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nancy that were permissive to R5 HIV-1 infection but to
a lesser extent than peripheral blood macrophages [5].
Recent findings demonstrate that HCs and MDMs
infected with HIV-1BaL have the same concentration of
integrated provirus [26], which suggests restriction in
viral replication is not a reflection of decreased HIV-1
entry; instead reduced HIV-1 replication may involve
intrinsic blocks unique to these cells [27]. Here, we
demonstrate that HCs assemble and release virus atrates comparable to MDMs; however, the overall tran-
scription of viral genes by HCs is significantly reduced.
These results suggest HCs express or produce intrinsic
factors, which may limit viral transcription following in-
fection, thereby offsetting MTCT. Contact-mediated
transfer of HIV-1 is an efficient mode of viral dissemin-
ation [28]. Since HCs can be productively infected with
HIV-1, we examined whether HIV-1 can be transmitted
through cell-to-cell contact from infected HCs to PHA-
stimulated autologous CBMCs or allogenic PBLs. Given
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at the placental interface, cell-mediated transmission
of HIV-1 may be a plausible mechanism of viral dis-
semination following primary infection of HCs. We
report that HIV-1-infected HCs have a limited capacity
to transmit virus to neighboring CBMCs compared to
MDMs.
Recently, regulatory macrophages have been character-
ized as a broad category of macrophages whose primary
role is to dampen the inflammatory immune response.
These regulatory macrophages produce high concentra-
tions of immunoregulatory cytokines (i.e. IL-10 and
TGF-β) and are potent inhibitors of inflammation, des-
pite their ability to secrete many Th1-type cytokines [15].
IL-10, specifically, is a prototypic regulatory cytokine
involved in the deactivation of macrophages [29]. Our
group and others have shown that IL-10 is produced
constitutively by HCs at significantly higher concentra-
tions than in MDMs [30,31]. In addition, we demonstrate
that IL-10 inhibits HIV-1 replication in HCs and propose
that the high basal production of IL-10 in HCs, similar to
regulatory macrophages, plays a central role in limiting
their ability to replicate HIV-1 after initial infection,
which may offset vertical transmission. Our data also
demonstrate that HCs constitutively secrete high con-
centrations of TGF-β. Studies have shown that TGF-β
and IL-10 drive the differentiation and activation of
CD4 + CD25highFoxP3+ T regulatory cells [32-34]. T
regulatory cells are present in the decidua [35], and a
reduction of these cells during pregnancy is associated
with spontaneous abortions [36]. In addition, we dem-
onstrate that exogenous TGF-β restricts HIV-1 replica-
tion in HCs. Interestingly; other investigators have noted
that TGF-β may inhibit MTCT of HIV-1 in breast milk
[37]. We propose that HCs may function as regulatory
macrophages in the placenta through the induction of
immunoregulatory cytokines, which limit HIV-1 replica-
tion and induce T regulatory cells within the placenta.
TNF-α had opposite effects on HIV-1 replication in
HCs. We have shown that HCs produce elevated con-
centrations of TNF-α compared to MDMs. TNF-α has a
pivotal role during parturition [38]. Over-production of
TNF-α may cause damage to the placental barrier,
allowing transfer of HIV-1 [39] and induction of viral
replication [40]. Our data show that exogenous TNF-α
significantly up-regulated HIV-1 replication in HCs
in vitro which may account for why most vertical
transmission events occur during parturition. The up-
regulation of a pro-inflammatory cytokine at the feto-
maternal interface and by HCs is not incongruous with
this regulatory phenotype. Instead, this observation
emphasizes the importance of maintaining an appro-
priate spatial, temporal, and quantitative balance of
cytokines within the placental milieu.The β-chemokines, MIP-1α and MIP-1β are ligands
for CCR5 and induce migration through the chemokine
receptor CCR5, which is highly expressed on HCs and
MDMs. Previous time-lapse observation studies indicate
that HCs can migrate rapidly over the surface of adherent
fibroblastic cells [41]. Here, we show that HCs also have
the potential to migrate in a CCR5-mediated manner in
response to the β-chemokines. Despite the potential of
HC migration in response to CCR5 ligands, this cell type
was not detected in cord blood by flow cytometry. This
data may reflect observations that show chemotaxis is
deficient in neonates, reflecting reduced concentrations
of β-chemokines in cord blood [42].
Conclusion
We demonstrate the restricted ability of HIV-1 to replicate
in HCs, which may offset vertical transmission of HIV-1
through an induction of immunoregulatory cytokines.
Cytokine levels fluctuate during a normal pregnancy
[43]; our data suggest HCs are important mediators to
limit inflammatory cytokine responses within the feto-
maternal interface to favor regulatory cytokine predom-




With written informed consent, term (>37 weeks gesta-
tion) placentas from 40 HIV-1 and Hepatits B seronega-
tive women were obtained immediately following elective
caesarian section without labor from Grady Memorial
and Emory Midtown Hospitals in Atlanta, GA. Approval
of the study was granted from Emory University Institu-
tional Review Board and Grady Research Oversight
Committee.
Isolation and Culture of HCs and MDMs
In order to isolate HCs, the decidua basalis was dissected
from the placenta. The tissue was thoroughly washed in
Hank’s balanced salt solution (HBSS) to minimize per-
ipheral blood contamination and mechanically dispersed
in complete medium (RPMI supplemented with 10%
FBS, 1 mM L-glutamine, and 1% pen/strep). The minced
tissue was re-suspended in complete medium containing
1 mg/ml collagenase IV [Sigma Chemical Co., St. Louis,
MO], 10 U/ml dispase [Worthington Biochemical Corp.,
Lakewood, NJ], and 0.2 mg/ml of DNAse I [Sigma] and
incubated in a shaking water bath at 37°C for 1 hour.
The digested tissue was washed with PBS and passed
through a 70 μm cell strainer [BD Falcon, USA]. The
mononuclear cell population was isolated by density
gradient centrifugation on Histopaque-1077 [Sigma].
CD14+ Magnetic Cell Sorting was performed using
anti-CD14 magnetic beads [Miltenyi Biotech, Germany]
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late MDMs, PBMCs were obtained from the buffy
coats of healthy HIV-1 seronegative blood donors by
density gradient centrifugation. Isolated cells were
washed, re-suspended in RPMI containing pen/strep
(1%), glutamine (1%), and heat-inactivated normal
human serum (10%) [Mediatech, VA], and seeded into
75-cm2 flasks [Corning Inc., New York]. Non-adherent
cells were removed after 2 h of incubation at 37°C.
After 24 hours of culture, adherent cells were washed,
detached from the flask and counted. Adherent HCs
and MDMs were washed with cold EDTA/PBS and
detached by incubation with cold EDTA/PBS (2 mM)
for 30 min at 4°C. The cells were seeded into 24-well
plates and were cultivated for 7 additional days to pro-
mote full differentiation into MDMs.
Flow cytometric analysis of cell surface determinants
Cells were labeled with anti-CD14 (F), -CD80 (PE),
-CD83 (PE), -CD86 (APC), -HLA-DR (PE), -CCR5
(PerCp-Cy5.5), -CXCR4 (PE-Cy5), -CD4 (APC), and
–DC-SIGN (PE) [BD Biosciences, CA]. Briefly, Fc-
blocked HCs were incubated with the conjugate anti-
bodies, and unbound antibody washed from the cells.
After the final washes, cells were fixed in 1% paraformal-
dehyde, and cell surface expression was determined by
FACS analysis with FACSCanto [Becton Dickinson, CA],
and the results were analyzed with the FlowJo software
version 8.4.3 [Tree Star, OR].
Infection of HCs and MDMs with HIV-1BaL
The macrophage-tropic isolate, HIV-1BaL was a gift from
Jason Hammonds PhD of Emory University School of
Medicine. Macrophages were infected at 0.2 TCID50/cell
for 4 hours at 37°C. Cells were washed and fresh media
added to the cultures. To monitor viral production and
particle release, cell supernatants and lysates were col-
lected at days 0, 2, 3, 4, 6, 8, 9 10,, 12, 15, 18 and 21
post-infection. Viral replication and particle release was
detected by p24 released into the supernatant and cell-
associated p24 by ELISA [Advanced BioScience Labora-
tories, Inc., MD].
Real-time PCR
HCs and MDMs were infected at 0.2 TCID50/cell
for 4 hours at 37°C. Cells were washed, and fresh
media added to the cultures. After 6 days, cells were
harvested and mRNA was extracted using the RNAeasy
kit (Qiagen, Valencia, CA). The cDNA was transcribed
using QuantiTect RT kit (Qiagen). The primer sequences
were as follows: forward primer env (50-GGGGAC
CAGGGAGAGCATT-30) and reverse primer env (50-
TGGGTCCCCTCCTGAGGA-30); forward primer gag
(50- ACATCAAGCAGCCATGCAAAT-30) and reverseprimer gag (50- ATCTGGCCTGGTGCAATAGG-30).
Real-time PCR was performed using SYBR Green
(Qiagen). All reactions were run in triplicate using the
Applied Biosystems Prism 7500 Sequence Detection
System. Delta-Ct values from the calibrator and experi-
mental groups were measured by subtracting Ct values
from target versus the housekeeping transcript, 18S.
Each sample is expressed as fold-change relative to
HIV-1 infected MDMs.
MTT assay
Cell cytotoxicity was assessed by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT, Sigma)
mitochondrial dehydrogenase assay. Cells were incu-
bated with a 1: 10 dilution of MTT solution to cell
media for 20 min at 37 °C. The extent of MTT conver-
sion to formazan by mitochondrial dehydrogenase was
determined by measuring optical density at 490 nm
using a microplate reader (Molecular Devices, Sunny-
vale, CA). The ratio of optical density from treated cells
to optical density from control cells reflected the per-
centage of surviving cells.
Culture of human CBMCs and PBMCs
Cord blood samples were collected from umbilical cords
of full-term newborns born to HIV-1 seronegative
mothers. PBMCs were obtained from healthy, HIV-1
seronegative adults. CBMCs and PBMCs were separated
from heparinized whole-blood samples by density gradient
centrifugation on Ficoll-Hypaque [Sigma]. The isolated
mononuclear cells were washed in sterile PBS and once in
RPMI 1640, maintained in complete medium. CBMCs
and PBMCs were stimulated with PHA (5 μg/ml) [Sigma]
in the basic medium described above for 24–48 hours
prior to infection. Stimulated cells were challenged with
HIV-1 immediately following PHA stimulation. Following
HIV-1 infection, the PHA-stimulated cells were main-
tained in complete medium supplemented with IL-2
(100U/ml) [R&D Systems, Minneapolis, MN].
Co-culture assays
Adherent, HIV-1BaL infected HCs and MDMs were co-
cultured with CBMCs or PBMCs for 6 hours. Non-
adherent cells were gently removed and washed with
PBS, counted and plated in complete medium supple-
mented with IL-2. Viral replication was detected by p24
release into the supernatant by ELISA.
Cell culture and cytokine measurement
Cells (0.5 x106) were cultured with HIV-1BaL or alone
for 2 days. IL-4, IL-6, IL-10, TNF-α, TGF-β, and IFN-γ
concentrations were measured by Quantikine ELISA kit
[R&D Systems] according to manufacturer’s instructions.
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In order to analyze if exogenous IL-4, IL-6, IL-10, TNF-
α, TGF-β, and IFN-γ influenced HIV-1 replication, HCs
were pretreated for two hours with cytokines [R&D
Systems] then inoculated as described earlier with
HIV-1BaL. To monitor viral production, cell supernatants
were collected at days 0, 3, 6, 9, 12, 15, 18 and 21 post-
infection.
Migration assays
HCs and MDMs were re-suspended in RPMI containing
0.1% BSA and 2 x 105 cells, incubated with human
CCR5 monoclonal antibodies (5 μg/ml) or along for
15 min – 2 hours, and added to 24-2well Transwell
inserts with 8 μm pore polycarbonate membranes
(Corning). Inserts were placed in wells containing 600 μl
media plus chemoattractants and incubated at 37°C for
18 hours. Cells that migrated through the membrane
were stained and counted microscopically in five random
high-powered fields. Chemotactic responses are expressed
as CI, calculated by dividing the mean number of cells
migrating toward chemoattractants by that toward control
medium. MIP-1α and MIP-1β were used for chemotaxis
at 10 ng/ml (Peprotech, Rocky Hill, NJ).
Electron microscopy
HIV-1-infected HCs were fixed with 2.5% glutaraldehyde
in 0.1 M cacodylate buffer (pH 7.4) overnight at 4 degree
C, and then washed with the same buffer. The cells were
then post fixed with 1% osmium tetroxide and 1.5% po-
tassium ferrocyanide in 0.1 M cacodylate buffer for one
hour. The cells were subsequently rinsed with de-
ionized water, dehydration through an ethanol series
ending with absolute ethanol, and then embedded in
Eponate 12 resin. Ultrathin sections were cut on a RMC
PowerTome XL ultramicrotome at 70 nm, stained with
5% aqueous uranyl acetate and 2% lead citrate, and
examined on a JEOL IEM-1400 transmission electron
microscope equipped with Gatan UltraScan US1000.894
and Orius SC1000.832 CCD cameras.
Statistical analyses
Results were analyzed by a one-way analysis of variance
(ANOVA). Parametric data were analyzed by using Stu-
dent’s t test (two-tailed) in order to assess whether the
means of two normally distributed groups differed sig-
nificantly. All non-parametric data was analyzed using
Mann–Whitney U Test. All error bars represent the SE.
Additional files
Additional file 1: HIV-1 replication in HCs. HCs from multiple donors
(N = 16) infected by HIV-1BaL in vitro showed differences in HIV-replication
over time. HIV-1 replication was measured in the cell supernatants byHIV-1 p24 viral antigen ELISA. Data shown are expressed as the mean ±
SE of triplicate samples.
Additional file 2: HIV-1 replication in MDMs. MDMs from multiple
donors (n = 8) infected by HIV-1BaL in vitro showed differences in HIV-
replication over time. HIV-1 replication was measured in the cell
supernatants by HIV-1 p24 viral antigen ELISA. Data shown are expressed
as the mean ± SE of triplicate samples.
Additional file 3: EM of HIV-1 Infected HCs reveals Viral Assembly
at the Plasma Membrane and within Intracellular Compartments.
HIV-1Bal infected HCs were fixed and analyzed by standard electron
microscope processing procedures. Sections show intracellular
compartments with mature virions and immature assembly profiles (open
arrows) (A). Virus assembly/budding profiles were also observed on the
plasma membrane (PM) (B). Bars represent 0.2 μm for A and 0.1 μm for B.
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